We want to thank you and your colleagues for submitting great questions for our series of MDoutlook Quick Polls directly post-ASCO. Pulsing its global network of >62,000 cancer treaters, MDoutlook has already received more than 400 completed surveys from more than 20 countries.
Focusing on key new data presented in Melanoma, Lung Cancer, Renal Cell Carcinoma, Prostate Cancer, Colorectal Cancer and Hepatocellular Carcinoma, we will be distributing the results in 4 reports. Follow this link for the first report: MDoutlook ASCO 2012 QP – Melanoma.
MDoutlook activities are predicated on 3 critical principles: 1) Relevant and accurate insight directly from pre-validated treaters; 2) Robust coverage and 3) Rapid response. Our post-ASCO Quick Polls have generated responses from more than 2,000 cancer treaters in 35 countries over the last 5 years, with insight delivered within 5 business days from fielding.
We continue our collaboration with our friends at Oncology Business Review (OBR) for distribution of this report; their Editor’s Blog has a copy of the results.
If you have any questions or would like to discuss how MDoutlook can support your oncology intelligence needs, please email me directly.
President, The Arcas Group